Braden B |
The best and worst treatments for Helicobacter pylori. |
2015 |
BMJ |
pmid:26290321
|
Zhang T |
Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites. |
2015 |
Eur J Pharm Sci |
pmid:26116278
|
Fraser LA et al. |
Calcium channel blocker-clarithromycin drug interaction did not increase the risk of nonvertebral fracture: a population-based study. |
2015 |
Ann Pharmacother |
pmid:25429094
|
Lee SJ et al. |
Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice. |
2015 |
PLoS ONE |
pmid:26114656
|
Tojima I et al. |
Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium. |
2015 |
Auris Nasus Larynx |
pmid:25769240
|
Nonaka L et al. |
Novel macrolide-resistance genes, mef(C) and mph(G), carried by plasmids from Vibrio and Photobacterium isolated from sediment and seawater of a coastal aquaculture site. |
2015 |
Lett. Appl. Microbiol. |
pmid:25765542
|
Tsunemine H et al. |
[Successful treatment of relapsed and refractory multiple myeloma by using clarithromycin-lenalidomide, low-dose dexamethasone(BiRd), and melphalan-prednisolone(MP)]. |
2015 |
Gan To Kagaku Ryoho |
pmid:25981655
|
Ribaldone DG et al. |
Efficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy. |
2015 |
Panminerva Med |
pmid:25971330
|
Thellin O et al. |
In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media. |
2015 |
Int. J. Antimicrob. Agents |
pmid:25963337
|
Hwang JJ et al. |
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease. |
2015 |
World J. Gastroenterol. |
pmid:25945019
|
Molina-Infante J et al. |
Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. |
2015 |
Aliment. Pharmacol. Ther. |
pmid:25776067
|
Takahashi C et al. |
Observation of antibacterial effect of biodegradable polymeric nanoparticles on Staphylococcus epidermidis biofilm using FE-SEM with an ionic liquid. |
2015 |
Microscopy (Oxf) |
pmid:25757698
|
Zhou Z et al. |
Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25451048
|
Hur J et al. |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. |
2015 |
Chem. Res. Toxicol. |
pmid:25811541
|
Trespalacios AA et al. |
Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA. |
2015 |
Diagn. Microbiol. Infect. Dis. |
pmid:25600075
|
Yoshida S et al. |
Investigation of the population structure of Mycobacterium abscessus complex strains using 17-locus variable number tandem repeat typing and the further distinction of Mycobacterium massiliense hsp65 genotypes. |
2015 |
J. Med. Microbiol. |
pmid:25596119
|
Ontsira Ngoyi EN et al. |
Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo. |
2015 |
Helicobacter |
pmid:25585658
|
Spaniol V et al. |
Moraxella catarrhalis AcrAB-OprM efflux pump contributes to antimicrobial resistance and is enhanced during cold shock response. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25583725
|
Chu HS et al. |
Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense. |
2015 |
PLoS ONE |
pmid:25581038
|
Lee H et al. |
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea. |
2015 |
Dig Liver Dis |
pmid:25467826
|
Kobayashi M et al. |
A sudden cardiac death induced by sildenafil and sexual activity in an HIV patient with drug interaction, cardiac early repolarization, and arrhythmogenic right ventricular cardiomyopathy. |
2015 |
Int. J. Cardiol. |
pmid:25464498
|
Mailleux M et al. |
Unusual pulmonary toxicity of ipilimumab treated by macrolides. |
2015 |
Acta Clin Belg |
pmid:26790556
|
Gisbert JP et al. |
Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy. |
2015 |
Dig. Dis. Sci. |
pmid:25236423
|
Ersal T et al. |
Fatal disseminated infection with Fusarium petroliphilum. |
2015 |
Mycopathologia |
pmid:25234793
|
Baumann M et al. |
Aquatic toxicity of the macrolide antibiotic clarithromycin and its metabolites. |
2015 |
Chemosphere |
pmid:25051235
|
Kakked GA et al. |
Pneumobilia with gastric outlet obstruction. |
2015 |
BMJ Case Rep |
pmid:26552878
|
Rubio M et al. |
Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex. |
2015 |
PLoS ONE |
pmid:26448181
|
Blair PW et al. |
DRESS syndrome presenting after initiation of mycobacterium avium complex osteomyelitis treatment. |
2015 |
BMJ Case Rep |
pmid:26438676
|
Zhi D et al. |
The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides. |
2015 |
Eur J Pharm Sci |
pmid:25976224
|
Dingemanse C et al. |
Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. |
2015 |
Carcinogenesis |
pmid:26320104
|
Obregón-Henao A et al. |
Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26303795
|
Pea F et al. |
Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia. |
2015 |
Transpl Infect Dis |
pmid:26296391
|
Picoli SU et al. |
Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients. |
2014 May-Jun |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:24878996
|
UÄŸurlu T et al. |
Optimization and evaluation of clarithromycin floating tablets using experimental mixture design. |
2014 Mar-Apr |
Acta Pol Pharm |
pmid:25272652
|
Skvarc M et al. |
Multi locus sequence typing (MLST) used as a tool to confirm the ability of susceptible Helicobacter pylori strains to gain resistance to clarithromycin during eradication therapy. |
2014 Jan-Feb |
Hepatogastroenterology |
pmid:24895826
|
Kakuda TN et al. |
Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies. |
2014 |
J. Antimicrob. Chemother. |
pmid:24155058
|
Kathariya R et al. |
Evaluation of subgingivally delivered 0.5% clarithromycin as an adjunct to nonsurgical mechanotherapy in the management of chronic periodontitis: a short-term double blinded randomized control trial. |
2014 |
J Investig Clin Dent |
pmid:23097216
|
Maev IV et al. |
[Eradication therapy for Helicobacter pylori infection: review of world trends]. |
2014 |
Ter. Arkh. |
pmid:24779078
|
Katagiri S et al. |
[Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia]. |
2014 |
Nippon Naika Gakkai Zasshi |
pmid:24796145
|
Altman E et al. |
Lipopolysaccharide glycotyping of clarithromycin-resistant and clarithromycin-susceptible Canadian isolates of Helicobacter pylori. |
2014 |
Can. J. Microbiol. |
pmid:24392924
|
Veraldi S et al. |
Treatment of sporotrichoid fish tank granuloma with pulsed clarithromycin. |
2014 |
Dermatology (Basel) |
pmid:25228273
|
Phillips RO et al. |
Reply to "compliance with antimicrobial therapy for buruli ulcer". |
2014 |
Antimicrob. Agents Chemother. |
pmid:25225343
|
Elkhatib W and Noreddin A |
Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model. |
2014 |
Microb. Drug Resist. |
pmid:25050970
|
Ohe M and Bohgaki T |
Successful treatment with clarithromycin for patients with polymyalgia rheumatica. |
2014 |
Korean J. Intern. Med. |
pmid:25045305
|
Dalbøge CS et al. |
Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis. |
2014 |
J. Cyst. Fibros. |
pmid:24035278
|
DiCicco M et al. |
In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius. |
2014 |
BMC Microbiol. |
pmid:24886369
|
Noonan KA et al. |
Targeting immune suppression with PDE5 inhibition in end-stage multiple myeloma. |
2014 |
Cancer Immunol Res |
pmid:24878583
|
Gong EJ et al. |
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change? |
2014 |
J. Korean Med. Sci. |
pmid:24851029
|
Tursi A et al. |
Decreasing efficacy of the standard seven-day triple therapy containing amoxycillin and clarithromycin in curing Helicobacter pylori infection in clinical setting in Italy: a 10-year follow-up study. |
2014 |
Panminerva Med |
pmid:24637473
|
Wei Z et al. |
Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients. |
2014 |
Helicobacter |
pmid:24617669
|